Citation Impact
Citing Papers
Guideline for disinfection and sterilization in healthcare facilities, 2008
2008 Standout
Recent Insights into Neuroendocrine Mechanisms of Aging of the Human Male Hypothalamic‐Pituitary‐Gonadal Axis
1999
Nonsteroidal anti-inflammatory drugs (NSAIDS) versus opioids for acute renal colic
2004
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
Results of a European Comparative Randomized Study Comparing Oral Bropirimine versus Intravesical BCG Treatment in BCG-Naive Patients with Carcinoma in situ of the Urinary Bladder
1999
Incidence and Risk Factors of Bacteriuria after Transurethral Resection of the Prostate
2001
Guideline for Prevention of Surgical Site Infection, 1999
1999 Standout
BCG (Bacillus of Calmette Guerin) therapy of high-risk superficial bladder cancer
2002
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
Intravesical bacillus Calmette‐Guérin is superior to mitomycin C in reducing tumour recurrence in high‐risk superficial bladder cancer: a meta‐analysis of randomized trials
2004
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
2006 Standout
Long-term follow-up of an EORTC randomized prospective trial comparing intravesical bacille calmette-guérin–RIVM and mitomycin c in superficial bladder cancer
1998
Bladder cancer
2016 Standout
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
Consensus Guidelines for the Management of Postoperative Nausea and Vomiting
2013 Standout
Photodynamic therapy and anti-tumour immunity
2006 Standout
Age Trends in the Level of Serum Testosterone and Other Hormones in Middle-Aged Men: Longitudinal Results from the Massachusetts Male Aging Study
2002 Standout
Japanese guidelines for prevention of perioperative infections in urological field
2007
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
2009 Standout
Surgical antibiotic prophylaxis
1995
Bladder cancer: Epidemiology, staging and grading, and diagnosis
2005 Standout
EAU Guidelines on Diagnosis and Conservative Management of Urolithiasis
2015 Standout
Long-term Efficacy of Maintenance Bacillus Calmette-Guérin versus Maintenance Mitomycin C Instillation Therapy in Frequently Recurrent TaT1 Tumours without Carcinoma In Situ: A Subgroup Analysis of the Prospective, Randomised FinnBladder I Study with a 20-Year Follow-up
2009
High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder
2005
Intravesical immunoprophylaxis in recurrent superficial bladder cancer (stage T1): Multicenter trial comparing bacille calmette-guérin and interferon-alpha
1997
Antibiotic prophylaxis and infection control measures in minimally invasive surgery
1995
An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer
2009
A Comparison of Regional Versus General Anesthesia for Ambulatory Anesthesia: A Meta-Analysis of Randomized Controlled Trials
2005
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
2008 Standout
BACILLUS CALMETTE-GUERIN VERSUS CHEMOTHERAPY FOR THE INTRAVESICAL TREATMENT OF PATIENTS WITH CARCINOMA IN SITU OF THE BLADDER: A META-ANALYSIS OF THE PUBLISHED RESULTS OF RANDOMIZED CLINICAL TRIALS
2005
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
Emodin modulates epigenetic modifications and suppresses bladder carcinoma cell growth
2013
Guideline for Prevention of Surgical Site Infection, 1999
1999 Standout
Alternating mitomycin C and bacillus Calmette-Guerin instillation prophylaxis for recurrent papillary (stages Ta to T1) superficial bladder cancer. Finnbladder Group.
1996
Alternating Mitomycin C and Bacillus Calmette-Guerin Instillation Therapy for Carcinoma in Situ of the Bladder
1995
5-YEAR FOLLOWUP OF A RANDOMIZED PROSPECTIVE STUDY COMPARING MITOMYCIN C AND BACILLUS CALMETTE-GUERIN IN PATIENTS WITH SUPERFICIAL BLADDER CARCINOMA
1999
Aloe‐emodin: A review of its pharmacology, toxicity, and pharmacokinetics
2019 Standout
Bladder Cancer
2020 Standout
Emodin: A Review of its Pharmacology, Toxicity and Pharmacokinetics
2016 Standout
Return hospital visits and morbidity within 60 days after day surgery: a retrospective study of 18,736 day surgical procedures
2006
ANTIBIOTIC PROPHYLAXIS FOR TRANSURETHRAL PROSTATIC RESECTION IN MEN WITH PREOPERATIVE URINE CONTAINING LESS THAN 100,000 BACTERIA PER ML: A SYSTEMATIC REVIEW
2005
INHIBITION OF BLADDER CARCINOMA CELL ADHESION BY OLIGOPEPTIDE COMBINATIONS IN VITRO AND IN VIVO
2002
European Hernia Society guidelines on the treatment of inguinal hernia in adult patients
2009 Standout
Alternating Mitomycin C and Bacillus Calmette-Guerin Instillation Prophylaxis For Recurrent Papillary (Stages Ta to T1) Superficial Bladder Cancer
1996
Prospective Randomized Open Study Between Ciprofloxacin and a Combination of Sulfadiazine and Trimethoprim in Antibiotic Prophylaxis in Connection with Transurethral Prostatectomy
1996
PROPHYLATIC ANTIBIOTIC USE IN TRANSURETHRAL PROSTATIC RESECTION: A META-ANALYSIS
2002
Alternating mitomycin C and bacillus Calmette-Guerin instillation therapy for carcinoma in situ of the bladder. The Finnbladder Group.
1995
Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee.
1999 Standout
Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes
2012 Standout
Intravesical Bacillus Calmette-Guerin Reduces the Risk of Progression in Patients with Superficial Bladder Cancer: A Meta-analysis of the Published Results of Randomized Clinical Trials
2002 Standout
Works of J. Permi being referenced
Analgesia and discharge following preincisional ilioinguinal and iliohypogastric nerve block combined with general or spinal anaesthesia for inguinal herniorrhaphy
2004
Effects of oestrogen treatment on serum gonadotrophin bioactivity, immunoreactivity and isohormone distribution, and on immunoreactive inhibin levels, in prostatic cancer patients
1994
Intravesical Chemotherapy (Mitomycin C) versus Immunotherapy(Bacillus Calmette-Guérin) in Superficial Bladder Cancer
1991
Randomized Controlled Study of Chemoprophylaxis in Transurethral Prostatectomy
1993
Intravenous indomethacin in the treatment of ureteric colic. A clinical multicentre study with pethidine and metamizol as the control preparations.
1983
Effect of Mitomycin C and Doxorubicin Instillation on Carcinoma insitu of the Urinary Bladder
1986